Melqart
PEN · Health care

Penumbra

Makes thin tubes doctors use to pull blood clots out of the body.
Bought more
Melqart owns 185,734 shares of Penumbra, worth about $59 million. That’s $6 of every $100 they have in stocks. Between April and June they bought 103,912 more (up 127%).
Mar 31
81,822
Jun 30
185,734

The numbers

Shares they own
185,734
Change since Mar 31
+103,912
+127.0%
Shares on Mar 31
81,822
Value on Jun 30, 2026
$58,645,511
about $59 million
Share of their money
5.6%
$6 of every $100 · 6th of 40
Price per share on Jun 30
$315.75
Cost of the shares they added
about $33 million
at the Jun 30 price
Kind
Shares
Also owned by
No other fund we follow
More about Penumbra
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works